Advocacy in Action (January 2026): Legislative Preview
Barb Conant • January 2, 2026
2026 Legislative Preview
The 2026 session promises to be as fast-paced as last year's. Similar to 2025, leadership has adopted a compressed 90-calendar day session, scheduled to run from January 12 to April 11. Shorter breaks and deadlines will reduce the session by nearly a month.
It’s important to remember that with 125 members in the Kansas House of Representatives and 40 in the Senate, 84 House votes and 27 Senate votes are needed to put measures on the ballot as constitutional amendments or to override a veto. There are 88 Republicans and 37 Democrats in the House. The Senate breaks down to 31 Republicans and 9 Democrats.
Budget
The budget is the legislature's primary constitutional responsibility and will be its major focus. Budget chairs have signaled they are looking to cut $200 million in State General Funds, much of which could be directed at Medicaid. The legislature again plans to draft its own budget rather than using the governor’s as the starting point. From an advocacy perspective, committees will not have lengthy hearings on budget proposals, so it’s important for legislators to hear directly from stakeholders and constituents.
Federal issues, such as the shifting of $50-60 million for Supplemental Nutrition Assistance Program (SNAP) to the state, will compete for funding within the budget discussion. For example, the passage of the federal HR1 shifts approximately $40 million in costs to the state and adds $15-20 million in administrative expenses.
KABC Priorities
At the same time, the State has indicated it needs an additional allocation of $30 million in State General Funds to avoid creating a waiting list for people over 65 who need home and community-based services to remain in their homes. This could affect an estimated 600 older adults who are functionally and financially eligible for the Frail Elderly waiver services.
Avoiding a waiting list for these older adults is a high priority for KABC. We are actively working with a coalition of other stakeholders to advocate for this funding.
KABC continues to advocate for policies that support adequate staffing in adult care homes. Low staffing ratios directly contribute to poorer quality care, such as an increased use of antipsychotic drugs, higher and more severe situations of noncompliance.
Throughout the session, KABC monitors legislation and works with legislators and State policy makers to support person-centered policies and programs while protecting the rights of aging persons and those with disabilities. We encourage you to get acquainted with your elected officials. Your experiences and observations about long-term care in Kansas helps build their knowledge, giving them first-hand information about the needs of the people they serve.

On March 19, 2026, a Washington Post article highlighted a recent Office of Inspector General for the Department of Health and Human Services investigation that brought renewed national attention to a troubling reality inside America’s nursing homes: powerful antipsychotic drugs are being used not as treatment, but as control. The report found that some facilities are misdiagnosing residents with schizophrenia to justify prescribing antipsychotic medications. These drugs are often not approved for people with dementia and carry serious risks, including falls, strokes, and even death. In many cases, these medications are used to manage behaviors that are not dangerous, such as calling out, resisting care, or expressing distress. The result is what advocates have long warned about: the use of chemical restraints to sedate residents for staff convenience. A National Problem Decades in the Making The misuse of antipsychotic drugs in long-term care has been documented for years. In April 2024, KABC highlighted this issue in our advocacy work, noting that hundreds of thousands of nursing home residents nationwide are given antipsychotic medications, often without appropriate clinical justification. These drugs carry an FDA “black box” warning for use in older adults with dementia due to an increased risk of death. Federal efforts over the past decade have aimed to reduce unnecessary use, yet as of early 2026, approximately 17% of long-stay nursing home residents in the United States are still receiving antipsychotic medications. At the same time, recent federal policy discussions in March 2026 have raised concerns among advocates that loosening reporting requirements could reverse progress made in reducing inappropriate use. Kansas Is Not Immune This issue hits close to home. In 2022, the Kansas Legislature’s Senior Care Task Force released a report to the 2023 Legislature identifying the administration of antipsychotic medications and protections against abuse and neglect as critical areas for reform. The Task Force emphasized that these medications could have serious and even fatal consequences for older adults, particularly when used inappropriately. Advocates in Kansas have reported that up to 26% of nursing home residents, and nearly 40% of those with dementia, have been prescribed antipsychotic medications in recent years, despite well-documented risks. While some facilities have made progress, reductions in use have stalled in recent years, raising concerns that systemic issues remain unresolved. Why It Happens At its core, the misuse of antipsychotic drugs is often a symptom of deeper systemic problems, many of which have been exacerbated since the COVID-19 pandemic. Experts and investigators point to: Chronic understaffing, intensified since 2020 Lack of training in dementia care Pressure to manage behaviors quickly Lack of person-centered practices in care Gaps in oversight and accountability Non-drug approaches, like personalized care, meaningful activities, and addressing unmet needs, are widely recognized as best practice. But they require time, staffing, and resources that many facilities continue to lack in 2026. When those supports are missing, medication restraint becomes the default. What Proper Care Should Look Like Clinical guidance has long been clear, and yet remains unchanged in 2026. Antipsychotic medications should be a last resort, used only when: Non-drug interventions have failed The resident poses a risk to themselves or others The benefits outweigh the serious risks Even then, they should be used cautiously, closely monitored, and regularly reevaluated. The Path Forward for Kansas Kansas has an opportunity, and an obligation, to act. Building on the 2022 Senior Care Task Force recommendations, advocates continue in 2025–2026 to call for: Expanded access to geriatric mental health specialists Stronger oversight and enforcement Improved training in dementia and person-centered care Greater transparency for residents and families Meaningful solutions to the ongoing staffing crisis At its heart, this is about dignity. Older adults in Kansas adult care homes deserve care that respects their humanity, not treatment that silences it.





